Zinlirvimab

Modify Date: 2025-09-12 13:29:09

Use of Zinlirvimab

Zinlirvimab is a humanized IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop)[1][2].

Name	Zinlirvimab

Description	Zinlirvimab is a humanized IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop)[1][2].
Related Catalog	Signaling Pathways >> Anti-infection >> HIV Research Areas >> Infection
References	[1]. Kuritzkes DR. Broadly neutralizing antibodies and long-acting antiretroviral drugs as treatments for HIV. Curr Opin HIV AIDS. 2023 Jul 1;18(4):225-228. [2]. Zinlirvimab. IMGT/mAb-DB.

Description

Zinlirvimab is a humanized IgG1-λ2, HIV neutralising antibody targeting to HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop)[1][2].

Related Catalog

Signaling Pathways >> Anti-infection >> HIV

Research Areas >> Infection

References

No Any Chemical & Physical Properties